Your browser doesn't support javascript.
loading
Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.
Allocca, Clare M; Bledsoe, Marianna J; Albert, Monique; Anisimov, Sergey V; Bravo, Elena; Castelhano, Marta G; Cohen, Yehudit; De Wilde, Mieke; Furuta, Koh; Kozlakidis, Zisis; Martin, Dunja; Martins, Anabela; McCall, Shannon; Morrin, Helen; Pugh, Rebecca S; Schacter, Brent; Simeon-Dubach, Daniel; Snapes, Emma.
Affiliation
  • Allocca CM; Standards Coordination Office, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.
  • Bledsoe MJ; Independent Consultant and Deputy Editor, Biopreservation and Biobanking, Colorado Springs, Colorado, USA.
  • Albert M; Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Canada.
  • Anisimov SV; National BioService, Saint-Petersburg, Russia.
  • Bravo E; Research Coordination and Support Service, Italian National Institute of Health, Rome, Italy.
  • Castelhano MG; Cornell Veterinary Biobank, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Cohen Y; MIDGAM-Israel National Biobank for Research, Rehovot, Israel.
  • De Wilde M; Biobank Antwerp, UZA-UAntwerpen, Antwerp, Belgium.
  • Furuta K; Urayasu Warakuen Clinic, Urayasu, Japan.
  • Kozlakidis Z; Laboratory Service and Biobank Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Martin D; Laboratory Service and Biobank Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Martins A; Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH, Braunschweig, Germany.
  • McCall S; Micoteca da Universidade do Minho, Centro de Engenharia Biológica, Braga, Portugal.
  • Morrin H; Department of Pathology, Duke University Health System, Durham, North Carolina, USA.
  • Pugh RS; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Schacter B; Chemical Sciences Division, National Institute of Standards and Technology, Charleston, South Carolina, USA.
  • Simeon-Dubach D; CancerCare Manitoba/University of Manitoba, Winnipeg, Canada.
  • Snapes E; medservice, Biobanking Consulting & Services, Walchwil, Switzerland.
Biopreserv Biobank ; 18(6): 533-546, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33164554
ABSTRACT
The era of COVID-19 has brought about a number of novel challenges for the global biobanking community. To better position the biobanking community to cope with current and future challenges, the International Society for Biological and Environmental Repositories (ISBER) COVID-19 Response Task Force was convened to identify needs and gaps in biobanking tools (existing resources that support good practice), for example, standards, best practices, business, etc. and to make recommendations to benefit the community. Toward these goals, the Task Force assembled a set of questions to explore individual biobanks' experiences, with emphasis on identification of key challenges and approaches, including tools employed. A survey was designed with the use of these questions and administered by ISBER. This article presents a summary of the aggregated data obtained from the survey responses, illustrating some of the major issues encountered and identifying which tools the survey respondents found most useful. In particular, this article focuses on the challenges identified during the early months of the COVID-19 era. Recommendations are provided to support biobank emergency preparedness for the future, address lessons learned, and propose solutions to bridge identified gaps. The analysis and the complete survey dataset will also inform the larger Task Force goal to develop specific tool recommendations.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Biological Specimen Banks / Pandemics / SARS-CoV-2 / COVID-19 Type of study: Guideline Limits: Humans Language: En Journal: Biopreserv Biobank Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Biological Specimen Banks / Pandemics / SARS-CoV-2 / COVID-19 Type of study: Guideline Limits: Humans Language: En Journal: Biopreserv Biobank Year: 2020 Type: Article Affiliation country: United States